Karen Woerner
Guest
We just received a letter dated June 24, 2011 from AMGEN in regards to FDA update product labeling for Procrit/Epogen for patients with chronic kidney disease (CKD).The following is a link to the FDA prescribing information.
http://www.accessdata.fda.gov/scrip...seaction=Search.Label_ApprovalHistory#apphist
http://www.accessdata.fda.gov/scrip...seaction=Search.Label_ApprovalHistory#apphist